http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107475379-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 |
| filingDate | 2017-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107475379-B |
| titleOfInvention | Molecular marker for tumor diagnosis and prognosis detection, detection primer and kit thereof |
| abstract | The invention discloses a molecular marker for tumor diagnosis and prognosis detection, which is PRSS3 splice variant; wherein, the PRSS3 splice variant is PRSS3-V1, PRSS3-V2, PRSS3-V3 and/or PRSS3-V4, and the nucleotide sequences are respectively shown as SEQ ID No. 1-4. The invention further provides an RT-qPCR primer and a kit for detecting the molecular marker. The primer or the kit for detecting the PRSS3 splice variant can specifically detect the transcription level of the PRSS3 splice variant in samples such as cells, tissues, body fluid, secretion and the like, and the detection result obtained by the method can provide an evaluation method for individual diagnosis of tumors of patients and prognosis judgment of drug treatment. In addition, the detection method is simple and convenient to operate, accurate and stable, and has clinical application significance. |
| priorityDate | 2017-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 168.